Seeking Alpha: Boston Scientific continues to look pretty hopeless
"On the whole, Medtronic continues to look like the 800-lb gorilla in most of its markets. Although pacing performance was disappointing as the company anniversaried the Revo introduction, the ICD business is doing well. While St. Jude (STJ) continues to look like it has some momentum, Medtronic does appear to be picking up some incremental lead business. Boston Scientific (BSX) continues to look pretty hopeless."